Centiva Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Centiva Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.9K	Buy	+208	New	+$28.1K	﹤0.01%	1660
2024 Q3	–	Sell	-4,659	Closed	-$458K	–	2665
2024 Q2	$432K	Buy	+4,659	New	+$418K	0.01%	1249
2024 Q1	–	Sell	-53,878	Closed	-$5M	–	2329
2023 Q4	$4.81M	Buy	53,878 +51,378	+2,055%	+$3.82M	0.11%	165
2023 Q3	$183K	Buy	+2,500	New	+$200K	﹤0.01%	1400
2020 Q2	–	Sell	-3,928	Closed	-$387K	–	836
2020 Q1	$304K	Buy	+3,928	New	+$348K	0.01%	385
2019 Q4	–	Sell	-1,125	Closed	-$97.3K	–	938
2019 Q3	$86K	Buy	1,125 +632	+128%	+$52.5K	0.01%	566
2019 Q2	$43K	Sell	493 -176	-26%	-$15K	﹤0.01%	399
2019 Q1	$61K	Buy	+669	New	+$56.9K	﹤0.01%	293

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Centiva Capital's XBI Position: Q2 2026 in Review

Centiva Capital opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 208 shares worth $32.9K. The stake represents ﹤0.01% of the portfolio and ranks #1660 among its holdings. This is a return to the name: Centiva Capital previously reported a position in XBI as recently as Q2 2024.

Centiva Capital first reported a position in XBI in Q1 2019 and has held it in 8 quarters since. The position peaked at $4.81M in Q4 2023. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Centiva Capital held 208 shares of State Street SPDR S&P Biotech ETF worth $32.9K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Centiva Capital position in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1660 holding.
Centiva Capital first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and has held it in 8 quarters since.
Centiva Capital's State Street SPDR S&P Biotech ETF position peaked at $4.81M in Q4 2023.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.